US Patent Issued to XENAMED on Feb. 4 for "Extended release midodrine hydrochloride compositions and methods of use" (Minnesota Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,213,953, issued on Feb. 4, was assigned to XENAMED CORP. (St. Paul, Minn.).

"Extended release midodrine hydrochloride compositions and methods of use" was invented by Yogesh Dandiker (Edina, Minn.), Maulik Kiritkumar Panchal (Maple Grove, Minn.) and Xiao Yu (Maple Grove, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure provides pharmaceutical compositions comprising midodrine, a pharmaceutically acceptable salt thereof, desglymidodrine, or a pharmaceutically acceptable salt thereof, that can be administered to a human subject in need thereof. The disclosure also provides pharmaceutical compositions for treatment of orthostatic hypoten...